[시장보고서]칼시토닌 주사 시장 보고서(2025년)

칼시토닌 주사 시장 보고서(2025년)

Calcitonin Injection Global Market Report 2025

상품코드 : 1764270

리서치사 : The Business Research Company

발행일 : On Demand Report

페이지 정보 : 영문 175 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,490

￦ 6,501,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490

￦ 9,396,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490

￦ 12,292,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

칼시토닌 주사 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 8.2%로 성장할 전망이며, 9억 9,000만 달러로 성장이 예측됩니다. 예측 기간 동안 성장은 뼈 관련 치료에 대한 수요 증가, 바이오시밀러 경쟁의 출현, 신흥 시장에서의 수요 증가, 개별화 의료로의 전환, 칼시토닌의 대체 용도에 관한 연구 확대에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향에는 경비 및 주사투여 시스템 발전, 반감기 연장제제 개발, 바이오시밀러 칼시토닌 제제 도입, 골다공증 치료 접근법 혁신, 진단기술 개선 등이 있습니다.

골다공증의 유병률 상승은 향후 수년간 칼시토닌 주사 시장의 성장을 견인할 것으로 예측됩니다. 골다공증은 골밀도 저하 및 골절의 용이성이 특징적인 병태이며, 주로 노인, 특히 폐경 후 여성이 이환합니다. 이 유병률의 증가는 평균수명의 연장이 자연스러운 골량 감소 및 골다공증 위험의 상승에 기여하고 있기 때문에 세계 인구의 고령화가 주요 원인이 되고 있습니다. 칼시토닌 주사제는 칼슘 농도를 조절하고 뼈의 분해를 지연시킴으로써 골밀도를 유지하며 골다공증 관리에 중요한 역할을 하고 있습니다. 또한 투여가 용이하기 때문에 환자의 복약 애드히어런스가 향상되고 골절 위험도 줄입니다. 예를 들어 2024년 6월 호주 보건복지랩은 2022년 85만 3,600명(인구의 3.4%)이 골다공증 또는 골감소증에 이환돼 2,659명(기록된 전체 사망의 1.4%)이 사망했다고 보고했습니다. 이처럼 골다공증의 부담 증가가 칼시토닌 주사의 수요를 촉진하고 있습니다.

칼시토닌 주사 시장의 주요 기업은 치료 효과와 환자 결과를 개선하기 위해 USP 합성 주사제와 같은 혁신적인 제품의 개발을 중시하고 있습니다. USP 합성주사제는 미국약국방(USP)이 정하는 엄격한 품질, 순도, 강도, 동일성 기준에 준거한 합성활성성분으로 제제화되어 있습니다. 이러한 제품은 안전성과 치료 효과를 확보하기 위해 엄격한 조건 하에서 제조되고 있습니다. 예를 들어 2025년 2월 독일에 본사를 둔 제약사 프레제니우스카비는 증후성 골페젯병과 고칼슘혈증 치료용 USP 합성 칼시토닌 살몬 주사액을 출시했습니다. 이 무균 용액은 근육 내 또는 피하 투여용으로 설계되었으며, 1mL당 200USP 단위의 농도로 제공되며, 2mL 멀티 도즈 바이알(400USP 단위)로 포장되어 있습니다. 주사액은 2℃-8℃의 냉장 보관이 필요합니다. 칼슘 조정제로 작용하여 고칼슘혈증이나 폐경 후 골다공증 등 대체 요법이 적합하지 않은 경우에 적응하게 됩니다.

세계의 칼시토닌 주사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 칼시토닌 주사 시장 : 성장률 분석
세계의 칼시토닌 주사 시장 실적 : 규모 및 성장(2019-2024년)
세계의 칼시토닌 주사 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 칼시토닌 주사 : 전체 시장 규모(TAM)

제6장 시장 세분화

세계의 칼시토닌 주사 시장 : 칼시토닌 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
연어 칼시토닌
인간 칼시토닌
합성 칼시토닌
세계의 칼시토닌 주사 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
정맥내(IV) 주사
피하 주사
근육내 주사
세계의 칼시토닌 주사 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
직접 판매
온라인 약국
소매 약국
의료기관
세계의 칼시토닌 주사 시장 : 치료 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
골다공증 치료
패젯병 관리
고칼슘혈증 관리
골전이 치료
세계의 칼시토닌 주사 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
고령자 간병 시설
재택 헬스케어
세계의 칼시토닌 주사 시장 : 연어 칼시토닌별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
합성 연어 칼시토닌
재조합 연어 칼시토닌
세계의 칼시토닌 주사 시장 : 인간 칼시토닌별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
재조합 인간 칼시토닌
합성 인간 칼시토닌
세계의 칼시토닌 주사 시장 : 합성 칼시토닌별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
펩티드 기반 합성 칼시토닌
아날로그 합성 칼시토닌

제7장 지역별 및 국가별 분석

세계의 칼시토닌 주사 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 칼시토닌 주사 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

칼시토닌 주사 시장 : 경쟁 구도
칼시토닌 주사 시장 : 기업 프로파일
- Kaiser Permanente
- F. Hoffmann-La Roche AG
- Sanofi SA
- Novartis AG
- AstraZeneca plc

제31장 기타 주요 기업 및 혁신 기업

Eli Lilly and Company
Boehringer Ingelheim International GmbH
Viatris Inc.
Fresenius Kabi AG
Sun Pharmaceutical Industries Limited
Dr. Reddy's Laboratories Limited
Cipla Limited
Hikma Pharmaceuticals plc
Endo International plc
Asahi Kasei Pharma Corporation
Torrent Pharmaceuticals Limited
BCN Peptides SL
SG Pharmaceuticals Pvt Ltd
Leucadia Pharmaceuticals Inc.
Polypeptide Group AB

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

칼시토닌 주사 시장(2029년) : 새로운 기회를 제공하는 국가
칼시토닌 주사 시장(2029년) : 새로운 기회를 제공하는 부문
칼시토닌 주사 시장(2029년) : 성장 전략
- 시장 동향에 의한 전략
- 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Calcitonin injection is a medication used to treat a range of bone-related conditions by inhibiting bone resorption and increasing calcium excretion through the kidneys. It is commonly administered via subcutaneous or intramuscular injection and is often derived from salmon, which exhibits a similar but more potent effect compared to human calcitonin.

The main types of calcitonin injection include salmon calcitonin, human calcitonin, and synthetic calcitonin. Salmon calcitonin refers to a form of the hormone either synthesized or derived from salmon, known for its higher potency. These injections can be administered through various routes, such as intravenous (IV), subcutaneous, or intramuscular methods. Distribution channels for these medications include direct sales, online pharmacies, retail pharmacies, and healthcare institutions. Calcitonin injections fall under several drug classes, including treatments for osteoporosis, Paget's disease, hypercalcemia, and bone metastases. They are utilized by various end users, such as hospitals, specialty clinics, geriatric care facilities, and home healthcare providers.

The calcitonin injection market research report is one of a series of new reports from The Business Research Company that provides calcitonin injection market statistics, including calcitonin injection industry global market size, regional shares, competitors with a calcitonin injection market share, calcitonin injection market segments, market trends and opportunities, and any further data you may need to thrive in the calcitonin injection industry. This calcitonin injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The calcitonin injection market size has grown strongly in recent years. It will grow from $0.67 billion in 2024 to $0.73 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. Growth during the historic period can be attributed to the rising prevalence of osteoporosis, increased awareness of bone health, expansion of treatment options for postmenopausal women, the availability of government healthcare subsidies, and a growing geriatric population.

The calcitonin injection market size is expected to see strong growth in the next few years. It will grow to $0.99 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. Growth in the forecast period can be attributed to increasing demand for bone-related treatments, the emergence of biosimilar competition, rising demand in emerging markets, a shift toward personalized medicine, and expanding research into alternative applications of calcitonin. Key trends expected during this period include advancements in intranasal and injectable delivery systems, the development of extended half-life formulations, the introduction of biosimilar calcitonin products, innovation in osteoporosis treatment approaches, and improvements in diagnostic technologies.

The rising prevalence of osteoporosis is expected to drive the growth of the calcitonin injection market in the coming years. Osteoporosis is a condition marked by reduced bone density and increased susceptibility to fractures, primarily affecting older adults, particularly postmenopausal women. This growing prevalence is largely attributed to the aging global population, as extended life expectancy contributes to natural bone loss and a heightened risk of osteoporosis. Calcitonin injections play a key role in managing the condition by regulating calcium levels and slowing bone degradation, thereby helping to preserve bone density. Their ease of administration also enhances patient adherence and reduces the risk of fractures. For example, in June 2024, the Australian Institute of Health and Welfare reported that 853,600 people (3.4% of the population) were living with osteoporosis or osteopenia in 2022, accounting for 2,659 deaths, or 1.4% of all recorded deaths. Thus, the growing burden of osteoporosis is fueling demand for calcitonin injections.

Leading companies in the calcitonin injection market are emphasizing the development of innovative products such as USP synthetic injections to improve treatment efficacy and patient outcomes. USP synthetic injections are formulated with synthetically produced active ingredients that comply with the rigorous quality, purity, strength, and identity standards set by the United States Pharmacopeia (USP). These products are manufactured under stringent conditions to ensure safety and therapeutic effectiveness. For example, in February 2025, Fresenius Kabi, a Germany-based pharmaceutical company, launched a USP synthetic calcitonin salmon injection for the treatment of symptomatic Paget's disease of bone and hypercalcemia. This sterile solution is designed for intramuscular or subcutaneous use, provided at a concentration of 200 USP units per mL and packaged in a 2 mL multi-dose vial (400 USP units). The injection must be refrigerated between 2°C and 8°C. Acting as a calcium regulator, it is indicated for cases where alternative therapies are unsuitable, including hypercalcemia and postmenopausal osteoporosis.

In April 2022, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, acquired Custopharm Inc. for an undisclosed sum. This acquisition was intended to bolster Hikma's U.S. injectables division by broadening its product range, advancing its research and development capabilities, and accelerating growth in the generic sterile injectable market. Custopharm Inc., based in the U.S., develops calcitonin salmon injection marketed under the brand name Calcimar.

Major players in the calcitonin injection market are Kaiser Permanente, F. Hoffmann-La Roche AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Viatris Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Torrent Pharmaceuticals Limited, BCN Peptides S.L., SG Pharmaceuticals Pvt Ltd, Leucadia Pharmaceuticals Inc., Polypeptide Group AB.

North America was the largest region in the calcitonin injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in calcitonin injection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the calcitonin injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The calcitonin injection market consists of sales of combination therapy packs, single-dose and multi-dose vials, branded formulations and generic versions of calcitonin products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Calcitonin Injection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on calcitonin injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for calcitonin injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The calcitonin injection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type Of Calcitonin: Salmon Calcitonin; Human Calcitonin; Synthetic Calcitonin
2) By Route Of Administration: Intravenous (IV) Injection; Subcutaneous Injection; Intramuscular Injection
3) By Distribution Channel: Direct Sales; Online Pharmacy; Retail Pharmacy; Healthcare Institutions
4) By Therapeutic Application: Osteoporosis Treatment; Pagets Disease Management; Hypercalcemia Control; Bone Metastases Therapy
5) By End-User: Hospitals; Specialty Clinics; Geriatric Care Facilities; Home Healthcare
Subsegments:

1) By Salmon Calcitonin; Synthetic Salmon Calcitonin; Recombinant Salmon Calcitonin

2) By Human Calcitonin; Recombinant Human Calcitonin; Synthetic Human Calcitonin

3) By Synthetic Calcitonin; Peptide-Based Synthetic Calcitonin; Analog Synthetic Calcitonin

Companies Mentioned: Kaiser Permanente; F. Hoffmann-La Roche AG; Sanofi S.A.; Novartis AG; AstraZeneca plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Calcitonin Injection Market Characteristics

3. Calcitonin Injection Market Trends And Strategies

4. Calcitonin Injection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Calcitonin Injection Growth Analysis And Strategic Analysis Framework

5.1. Global Calcitonin Injection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Calcitonin Injection Market Growth Rate Analysis
5.4. Global Calcitonin Injection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Calcitonin Injection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Calcitonin Injection Total Addressable Market (TAM)

6. Calcitonin Injection Market Segmentation

6.1. Global Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Salmon Calcitonin
Human Calcitonin
Synthetic Calcitonin
6.2. Global Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV) Injection
Subcutaneous Injection
Intramuscular Injection
6.3. Global Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Sales
Online Pharmacy
Retail Pharmacy
Healthcare Institutions
6.4. Global Calcitonin Injection Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Osteoporosis Treatment
Pagets Disease Management
Hypercalcemia Control
Bone Metastases Therapy
6.5. Global Calcitonin Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Geriatric Care Facilities
Home Healthcare
6.6. Global Calcitonin Injection Market, Sub-Segmentation Of Salmon Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Synthetic Salmon Calcitonin
Recombinant Salmon Calcitonin
6.7. Global Calcitonin Injection Market, Sub-Segmentation Of Human Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Human Calcitonin
Synthetic Human Calcitonin
6.8. Global Calcitonin Injection Market, Sub-Segmentation Of Synthetic Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peptide-Based Synthetic Calcitonin
Analog Synthetic Calcitonin

7. Calcitonin Injection Market Regional And Country Analysis

7.1. Global Calcitonin Injection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Calcitonin Injection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Calcitonin Injection Market

8.1. Asia-Pacific Calcitonin Injection Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Calcitonin Injection Market

9.1. China Calcitonin Injection Market Overview
9.2. China Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Calcitonin Injection Market

10.1. India Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Calcitonin Injection Market

11.1. Japan Calcitonin Injection Market Overview
11.2. Japan Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Calcitonin Injection Market

12.1. Australia Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Calcitonin Injection Market

13.1. Indonesia Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Calcitonin Injection Market

14.1. South Korea Calcitonin Injection Market Overview
14.2. South Korea Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Calcitonin Injection Market

15.1. Western Europe Calcitonin Injection Market Overview
15.2. Western Europe Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Calcitonin Injection Market

16.1. UK Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Calcitonin Injection Market

17.1. Germany Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Calcitonin Injection Market

18.1. France Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Calcitonin Injection Market

19.1. Italy Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Calcitonin Injection Market

20.1. Spain Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Calcitonin Injection Market

21.1. Eastern Europe Calcitonin Injection Market Overview
21.2. Eastern Europe Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Calcitonin Injection Market

22.1. Russia Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Calcitonin Injection Market

23.1. North America Calcitonin Injection Market Overview
23.2. North America Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Calcitonin Injection Market

24.1. USA Calcitonin Injection Market Overview
24.2. USA Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Calcitonin Injection Market

25.1. Canada Calcitonin Injection Market Overview
25.2. Canada Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Calcitonin Injection Market

26.1. South America Calcitonin Injection Market Overview
26.2. South America Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Calcitonin Injection Market

27.1. Brazil Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Calcitonin Injection Market

28.1. Middle East Calcitonin Injection Market Overview
28.2. Middle East Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Calcitonin Injection Market

29.1. Africa Calcitonin Injection Market Overview
29.2. Africa Calcitonin Injection Market, Segmentation By Type Of Calcitonin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Calcitonin Injection Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Calcitonin Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Calcitonin Injection Market Competitive Landscape And Company Profiles

30.1. Calcitonin Injection Market Competitive Landscape
30.2. Calcitonin Injection Market Company Profiles
- 30.2.1. Kaiser Permanente Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Calcitonin Injection Market Other Major And Innovative Companies

31.1. Eli Lilly and Company
31.2. Boehringer Ingelheim International GmbH
31.3. Viatris Inc.
31.4. Fresenius Kabi AG
31.5. Sun Pharmaceutical Industries Limited
31.6. Dr. Reddy's Laboratories Limited
31.7. Cipla Limited
31.8. Hikma Pharmaceuticals plc
31.9. Endo International plc
31.10. Asahi Kasei Pharma Corporation
31.11. Torrent Pharmaceuticals Limited
31.12. BCN Peptides S.L.
31.13. SG Pharmaceuticals Pvt Ltd
31.14. Leucadia Pharmaceuticals Inc.
31.15. Polypeptide Group AB

32. Global Calcitonin Injection Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Calcitonin Injection Market

34. Recent Developments In The Calcitonin Injection Market

35. Calcitonin Injection Market High Potential Countries, Segments and Strategies

35.1 Calcitonin Injection Market In 2029 - Countries Offering Most New Opportunities
35.2 Calcitonin Injection Market In 2029 - Segments Offering Most New Opportunities
35.3 Calcitonin Injection Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer